Technical Analysis for BIAF - bioAffinity Technologies, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
20 DMA Resistance | Bearish | -4.51% | |
Bollinger Band Squeeze | Range Contraction | -4.51% | |
20 DMA Resistance | Bearish | -5.22% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -5.22% | |
Bollinger Band Squeeze | Range Contraction | -5.22% |
Alert | Time |
---|---|
10 DMA Resistance | about 17 hours ago |
1.5x Volume Pace | about 17 hours ago |
Down 5% | about 17 hours ago |
Down 3% | about 17 hours ago |
Fell Below Lower Bollinger Band | about 17 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Lung Cancer Molecular Diagnostics Diagnostic Tests Cancer Therapeutics
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Lung Cancer Molecular Diagnostics Diagnostic Tests Cancer Therapeutics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.62 |
52 Week Low | 1.21 |
Average Volume | 134,262 |
200-Day Moving Average | 1.99 |
50-Day Moving Average | 1.65 |
20-Day Moving Average | 1.34 |
10-Day Moving Average | 1.32 |
Average True Range | 0.11 |
RSI (14) | 38.65 |
ADX | 29.86 |
+DI | 12.82 |
-DI | 26.22 |
Chandelier Exit (Long, 3 ATRs) | 1.17 |
Chandelier Exit (Short, 3 ATRs) | 1.54 |
Upper Bollinger Bands | 1.42 |
Lower Bollinger Band | 1.26 |
Percent B (%b) | 0.09 |
BandWidth | 12.09 |
MACD Line | -0.09 |
MACD Signal Line | -0.11 |
MACD Histogram | 0.0133 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.44 | ||||
Resistance 3 (R3) | 1.44 | 1.38 | 1.41 | ||
Resistance 2 (R2) | 1.38 | 1.34 | 1.38 | 1.40 | |
Resistance 1 (R1) | 1.33 | 1.32 | 1.30 | 1.33 | 1.39 |
Pivot Point | 1.27 | 1.27 | 1.26 | 1.27 | 1.27 |
Support 1 (S1) | 1.22 | 1.23 | 1.19 | 1.22 | 1.15 |
Support 2 (S2) | 1.16 | 1.21 | 1.16 | 1.14 | |
Support 3 (S3) | 1.11 | 1.16 | 1.13 | ||
Support 4 (S4) | 1.11 |